StonvexLoading…
StonvexStonvexStonvexCore line items from JILL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-02-01 | Annual 2024 2024-02-03 | Annual 2023 2023-01-28 |
|---|---|---|---|---|
Revenue | $596.55M | $610.86M | $608.04M | $618.53M |
Operating Income | $50.61M | $75.70M | $86.05M | $78.73M |
Net Income | $27.89M | $39.48M | $36.20M | $42.17M |
EPS (Diluted) | $1.82 | $2.61 | $2.51 | $2.95 |
Total Assets | $450.22M | $417.70M | $428.18M | $466.42M |
Total Liabilities | $328.72M | $311.93M | $390.96M | $466.64M |
Cash & Equivalents | $41.02M | $35.43M | $62.17M | $87.05M |
Free Cash Flow OCF − CapEx | $25.21M | $50.77M | $52.62M | $65.24M |
Shares Outstanding | 14.87M | 15.32M | 10.61M | 10.17M |